Navigation Links
New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF
Date:6/30/2009

AMSTERDAM, The Netherlands, June 30 /PRNewswire/ --

- "Study Could Have Major Impact on the Decision-Making Process With Respect to Infertility Treatment"

New data from an economic analysis presented today at this year's European Society of Human Reproduction and Embryology (ESHRE) congress showed that, within the parameters of the simulation model used, the in vitro fertilisation (IVF) treatment MENOPUR (highly-purified human menopausal gonatropin or HP-hMG) offered considerable cost-savings over recombinant follicle stimulating hormone (rFSH).[1] The cost-effectiveness of HP-hMG compared with rFSH suggested by this data could make it a more attractive choice for use in infertility treatment within a fixed healthcare budget.

In today's difficult global financial situation, the cost-effectiveness of infertility treatments, such as IVF, is more important than ever. Experiencing fertility problems is deeply distressing and isolating for couples and the cost of treatment is one of many considerations for people seeking treatment. A recent audit of European infertility patient groups showed that infertile couples are calling for clear information on the cost-effectiveness, as well as the efficacy of individual treatments.[2]

HP-hMG and rFSH are two commonly used hormonal therapies belonging to the class of drugs known as gonadotropins that enhance egg production in IVF treatment. HP-hMG, contains both FSH and hCG-driven (human chorionic gonadotropin) LH-activity (luteinizing hormone). In contrast, rFSH is a recombinant product and contains only rFSH.

"Until recently, discussions regarding funding for infertility treatment services have been hindered by a relative paucity of economic studies of the specific treatments," points out study investigator Dr Jaro Wex from PharmArchitecture, UK.

"Our new study compared success rates and value for money of gonadot
'/>"/>

SOURCE Ferring Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
2. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
4. Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
5. New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
6. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
7. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
8. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
9. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
10. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
11. New Clinical Data Further Supports Chromium Picolinates Role in Enhancing Brain Activity in Older Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/45v9b3/urinary_slings ) ... Market in the US 2015-2019" report to their ... market in the US to grow at a CAGR ... report covers the present scenario and the growth prospects ... the period 2015-2019. To calculate the market size, the ...
(Date:7/6/2015)... 6, 2015 Array BioPharma,s (NASDAQ:   ... past weekend at the 2015 ESMO World Congress ... the meeting, data were shared from a Phase ... randomized Phase 2 expansion of that trial testing ... inhibitor, with or without the addition of alpelisib ...
(Date:7/6/2015)... BOSTON , July 6, 2015 ... Inc. (NASDAQ: ISIS ), announced today that ... Orphan Drug Designation to volanesorsen (ISIS-APOCIII Rx ) ... Syndrome (FCS).  FCS is a rare genetic disease ... of pancreatitis. In a Phase 2 study published ...
Breaking Medicine Technology:United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6
... , DEFUNIAK SPRINGS, Fla., Nov. 11 Professional Products, ... for nearly five decades, today announced its innovative new ... knee splint with a breathable, anti-migration wrap, the PKS ... from pain and edema in treating post-operative repairs, ligament ...
... WellTek/MedX Group, health, fitness and wellness companies, today announced ... facilitate becoming an SEC reporting company. , ... a wholly owned subsidiary of an SEC reporting public ... name to WellTek Incorporated. As a result of ...
Cached Medicine Technology:Knee Splint's Multi-Compartment Technology Speeds Rehabilitation from Injuries 2WellTek/MedX Group Completes Major Reorganization 2
(Date:7/5/2015)... ... July 06, 2015 , ... City Sports, the Boston-based specialty ... co-produce two training clinics for first-time triathletes this summer with ethos, the owner and ... on Thursday, July 9, at 6:00 p.m. at the North End Greenway. The event ...
(Date:7/5/2015)... ... ... Doctors at the Swedish Cancer Institute in Seattle, Washington say with careful ... for people with pleural mesothelioma. Surviving Mesothelioma has just posted the full story. ... patients treated with 25Gy of radiation over five days just prior to surgery had ...
(Date:7/4/2015)... ... ... gains access to someone’s email account, it can lead to all sorts of trouble, both ... issued a scam alert about a social engineering scam which cons a target into ... the hacker. All they have to do is click for a password reset and ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... Dori Friend opened registration for a new SEO training system called "Page ... guide for organic traffic generation has received glowing reviews from several well-known marketers. ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... exclusively to healthcare providers, has been retained to lead a national president ... executive search firms in the healthcare industry, B. E. Smith has recently placed ...
Breaking Medicine News(10 mins):Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3
... the Healthcare Information Technology Standards Panel (HITSP) to exchange patient ... ... 26, 2009 -- With the economic stimulus package under consideration, ... Tuesday,s inaugural address, with President Obama noting that he is ...
... Heart Association recommends that people consume at least ... omega-6 fatty acids.-- It,s recommended that the omega-6 ... with polyunsaturated fatty acids may lower the risk ... improve insulin resistance, reduce diabetes risk and lower ...
... that sociability, shyness might be hidden in DNA , , MONDAY, ... strands of DNA that make you human are genes that ... new study comparing the two types of twins shows that ... the discovery say they are closing in on some of ...
... having a private well or septic system, and other ... for bacterial intestinal infections not occurring in outbreaks. ... Salmonella outbreak involving peanut butter that has ... for only about 10 percent of intestinal infections, which ...
... Ala., Jan. 26 The National Center for Sports,Safety ... death of 15-year-old,Kentucky high school football player Max Gilpin ... School coach David Stinson on,Thursday. , ... and coaches of this young,man," said Dr. Larry Lemak, ...
... stresses risk is still low , , MONDAY, Jan. 26 (HealthDay ... of developing brain cancer at a young age has been ... malignant brain tumors and 238 people with no cancers. The ... type of brain cancer. Patients survive an average of 12 ...
Cached Medicine News:Health News:Achieving Interconnected Healthcare through HITSP Real-Life Scenarios 2Health News:Achieving Interconnected Healthcare through HITSP Real-Life Scenarios 3Health News:Achieving Interconnected Healthcare through HITSP Real-Life Scenarios 4Health News:Achieving Interconnected Healthcare through HITSP Real-Life Scenarios 5Health News:Achieving Interconnected Healthcare through HITSP Real-Life Scenarios 6Health News:American Heart Association Science Advisory - Omega-6 Fatty Acids: Make Them a Part of Heart-Healthy Eating 2Health News:American Heart Association Science Advisory - Omega-6 Fatty Acids: Make Them a Part of Heart-Healthy Eating 3Health News:American Heart Association Science Advisory - Omega-6 Fatty Acids: Make Them a Part of Heart-Healthy Eating 4Health News:Popular or Not? Your Genes May Help Decide 2Health News:Popular or Not? Your Genes May Help Decide 3Health News:Was it the chicken salad or the swim? 2Health News:Was it the chicken salad or the swim? 3Health News:National Center for Sports Safety Responds to Indictment of Kentucky Coach 2
The Incontinence Dish is used to relieve stress incontinence and minor degrees of prolapse. The Incontinence Dish comes with and without support. It is available in eight different sizes....
The Shaatz pessary, available in nine sizes, is used for a first to second degree prolapse and an accompanying cystocele....
... Burdick ABP Systems are among ... the market today, with advanced ... analysis of patient information. Extensive ... validated Burdick ABPM accuracy, making ...
The Capio CL Transvaginal Suture Capturing Device allows for a transvaginal suture fixation to Cooper's Ligament for sling procedures...
Medicine Products: